Skip to main content

Inappropriate Scripts Persist for Elderly in Primary Care


August 23, 2012 — Twenty percent of medicines for elderly people in primary care are inappropriately prescribed, despite recent efforts to improve the quality of medical prescriptions for seniors, according to a study published online August 22 in PLoS One.
Dedan Opondo, a PhD student from the Department of Medical Informatics, University of Amsterdam, the Netherlands, and colleagues conducted a systematic review of published literature on inappropriate medical prescription (IMP) for elderly people in primary care, with the last search conducted on March 8, 2012.
IMP can be defined as prescriptions that subject patients to significant risk for adverse drug reactions when evidence exists that another medication is equally or more effective, or a prescription of a medication that fails to achieve optimal effects. IMP can be characterized as under-, mis-, or overprescribing.
Of 946 articles screened, 19 were included in the final analysis, meeting the criteria of describing experiences of elderly people aged 65 years or older who received medical prescriptions in outpatient, primary care settings; in other words, studies met inclusion criteria if the setting was described as outpatient clinic, office practice, general practice, and/or primary health care clinic. Reporting was based on drug-age criteria. The analysis excludes institutionalized and community-dwelling seniors when the setting in which the medication was prescribed was not indicated.
The studies covered 11 countries, including the United States, 7 European countries (Italy, United Kingdom, the Netherlands, Germany, Ireland, Norway, and Portugal), Taiwan, Iran, and India. Most of the studies (15/19) used Beers criteria. Four studies used multiple criteria sets to assess appropriateness of medication use.
Overall, the median rate for IMPs came to 20.0% (absolute range, 2.9% - 38.5%; interquartile range, 16.8% - 25.4%), with US studies showing a median IMP rate of 19.6% (range, 4.5% - 33.3%) and European studies showing a median rate of 19.1% (range, 2.9% - 38.5%).
When the researchers grouped prescriptions by therapeutic classes, they found that the analgesic propoxyphene had the highest median IMP rate, at 4.52% (range, 0.10% - 23.30%), followed by the antihypertensive doxazosin (3.96%; range, 0.32% - 15.70%), the anticholinergic diphenhydramine (3.30%; range, 0.02% - 4.40%), the antidepressant amitriptyline (3.20%; range, 0.05% - 20.5%), the antiarrhythmic digoxin (3.10%; range, 0.01% - 21.1%), the anticholinergic clidinium (3.1%; range, 3.01% - 3.1%), and the sedative hypnotic diazepam (2.74%; range, 0.05% - 30.0%). The anticholinergic belladonna alkaloids had the lowest IMP rate (0.04%; range, 0.0% - 0.5%).
Diphenhydramine and amitriptyline were the most common high-risk drugs inappropriately prescribed, whereas propoxyphene and doxazosin were the most common low-risk drugs inappropriately prescribed.
"This review found that one in five (20.0%) prescriptions to elderly persons is inappropriate with marked variation of rates of IMP within individual therapeutic classes," the researchers write. They point out that of the 19 studies, 16 were published after 2000, and even though much attention has focused on IMP and elderly people in the past 11 years, the rate seems not to have gone down.
Factors that may have contributed to the wide range of variation in IMP (ie, 2.9% - 38.5%) include lack of a universal list of recommended medications among different countries, regional differences in cost and purchasing systems for specific medications, and variation in local drug procurement policies and structure of medication financing.
The researchers write that prescriptions for high-risk medications such as diazepam and nifedipine subject elderly people to "frequent and severe adverse drug events," and that interventions such as clinical decision support systems need to be used. "These systems can provide alerts during prescription based on medication prescription guidelines such as the Beers criteria," they write.
Limitations of their study include possible publication bias among the 19 studies, plus possible relevance among the other studies not included in this analysis. Strengths include the analysis within therapeutic classes.
"This analysis is useful to policy makers and clinicians when making choices between medications from the same therapeutic class. We also compared IMP in studies which utilised multiple instruments to measure quality of prescription," the researchers write.
They conclude, "Focused and systematic interventions are needed to improve the quality of medication prescription in this patient group."
The authors have disclosed no relevant financial relationships.

Comments

Popular posts from this blog

Contact Precautions May Have Unintended Consequences

Contact precautions, including gloves, gowns, and isolated rooms, have helped stem the transmission of hospital pathogens but have also had some negative consequences, according to findings from a new study. Healthcare worker (HCWs) visited patients on contact precautions less frequently than other patients and spent less time with those patients when they did visit, report Daniel J. Morgan, MD, from the University of Maryland School of Medicine and the Veterans Affairs (VA) Maryland Health Care System, Baltimore, and colleagues. Moreover, patients on contact precautions also received fewer outside visitors. "Less contact with HCWs suggests that other unintended consequences of contact precautions still exist," Dr. Morgan and coauthors write. "The resulting decrease in HCW contact may lead to increased adverse events and a lower quality of patient care due to less consistent patient monitoring and poorer adherence to standard adverse event prevention methods (such...

Obama Renominates Tavenner to Be CMS Chief

President Barack Obama yesterday renominated Marilyn Tavenner, the acting administrator of the Centers for Medicare & Medicaid Services (CMS), to serve in that post without the caveat of "acting" attached to it. If the Senate approves her nomination, Tavenner will be the first confirmed, full-fledged CMS administrator since Mark McClellan, MD, PhD, stepped down from that position in October 2006, during the George W. Bush administration. Dr. McClellan's successors either were acting administrators or, in the case of Donald Berwick, MD, who was Tavenner's immediate predecessor, a recess appointment. As illustrated by Dr. Berwick's  CMS history , Senate confirmation can be tough to get when one party has enough votes to filibuster and otherwise stymie a nomination by an opposing party's president. That was the case when Obama nominated Dr. Berwick, whom Senate Republicans portrayed as an advocate of healthcare rationing, a characterization denied by t...

Secondary Prevention: Clinical Approaches to Managing the Higher-Risk Patient with Heart Disease

INCIDENCE/PREVALENCE/BURDENS ASSOCIATED WITH CARDIOVASCULAR DISEASE (CVD) The prevention of an initial and recurrent cardiovascular event and other complications, such as diabetes and kidney failure [also known as end-stage renal disease (ESRD) or chronic kidney disease (CKD) stage 5] is an important goal in patients with a history of CVD. Each year, approximately 185,000 Americans suffer a recurrent stroke, approximately 470,000 will have a recurrent coronary attack, and an estimated 325,000 will suffer a recurrent myocardial infarction. [1]  Secondary prevention strategies offer the opportunity to prevent further complications and improve outcomes by early detection and management of common comorbidities. The burden on public health and the costs associated with chronic illnesses such as CVD, CKD, and diabetes remain high. An estimated 82.6 million American adults (1 in 3) have 1 or more types of CVD. [1]  Heart failure is the fastest-growing clinical cardiac disease ...